Neurotransmitter aberrations in schizophrenia: New perspectives and therapeutic implications

被引：162
作者：
Carlsson, A
Hansson, LO
Waters, N
Carlsson, ML
机构：
来源：
LIFE SCIENCES | 1997年 / 61卷 / 02期
关键词：
neurotransmitters; glutamate deficiency hypothesis of schizophrenia; gender; psychotogenic neurocircuitries; thalamus; schizophrenia;
D O I：
10.1016/S0024-3205(97)00228-2
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
The dopamine hypothesis has dominated schizophrenia research for decades but is now yielding to a more diversified view, where the interaction of several neurotransmitters in complex circuitries is under scrutiny. Especially, glutamatergic and serotonergic mechanisms are attracting attention. However, the role of dopamine also needs further exploration and may still turn out to have novel therapeutic applications. III the present minireview an attempt is made to integrate preclinical and clinical data on neurotransmitter aberrations in schizophrenia and to discuss their therapeutic implications.
引用
收藏
页码：75 / 94
页数：20
相关论文
共 67 条
[41]   MOTOR EFFECTS OF THE PARTIAL DOPAMINE AGONIST (-)-3-(3-HYDROXYPHENYL)-N-N-PROPYLPIPERIDINE (PRECLAMOL) IN PARKINSONS-DISEASE [J].
METMAN, LV ;
SETHY, VH ;
ROBERTS, JR ;
BRAVI, D ;
HOFF, JI ;
MOURADIAN, MM ;
CHASE, TN .
MOVEMENT DISORDERS, 1994, 9 (05) :577-581
[42]   Effects of MK-801 on spontaneous and amphetamine-stimulated dopamine release in striatum measured with in vivo microdialysis in awake rats [J].
Miller, DW ;
Abercrombie, ED .
BRAIN RESEARCH BULLETIN, 1996, 40 (01) :57-62
[43]   MK-801 POTENTIATES DOPAMINERGIC-D1 BUT REDUCES D2 RESPONSES IN THE 6-HYDROXYDOPAMINE MODEL OF PARKINSONS-DISEASE [J].
MORELLI, M ;
DICHIARA, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 182 (03) :611-612
[44]   FURTHER STUDIES ON ACCUMULATION AND DISAPPEARANCE OF CATECHOLAMINES FORMED FROM TYROSINE-C-14 IN MOUSE BRAIN - EFFECT OF SOME PHENOTHIAZINE ANALOGUES [J].
NYBACK, H ;
SEDVALL, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1970, 10 (02) :193-&
[45]  
Penney J B Jr, 1986, Mov Disord, V1, P3, DOI 10.1002/mds.870010102
[46]   PRECLAMOL AND PARKINSONIAN FLUCTUATIONS [J].
PIRTOSEK, Z ;
MERELLO, M ;
CARLSSON, A ;
STERN, G .
CLINICAL NEUROPHARMACOLOGY, 1993, 16 (06) :550-554
[47]   THE ROLE OF 5-HT2A RECEPTORS IN ANTIPSYCHOTIC ACTIVITY [J].
SCHMIDT, CJ ;
SORENSEN, SM ;
KEHNE, JH ;
CARR, AA ;
PALFREYMAN, MG .
LIFE SCIENCES, 1995, 56 (25) :2209-2222
[48]   ANTIPSYCHOTIC DRUG DOSES AND NEUROLEPTIC-DOPAMINE RECEPTORS [J].
SEEMAN, P ;
LEE, T ;
CHAUWONG, M ;
WONG, K .
NATURE, 1976, 261 (5562) :717-719
[49]   SUBSTITUTED (S)-PHENYLPIPERIDINES AND RIGID CONGENERS AS PREFERENTIAL DOPAMINE AUTORECEPTOR ANTAGONISTS - SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS [J].
SONESSON, C ;
LIN, CH ;
HANSSON, L ;
WATERS, N ;
SVENSSON, K ;
CARLSSON, A ;
SMITH, MW ;
WIKSTROM, H .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (17) :2735-2753
[50]  
STARR MS, 1993, J NEURAL TRANSM-PARK, V6, P215
1234567